Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons ... | RTCL.TV

Dr. Stanley Plotkin: Correlates of Protection by VaccinesПодробнее

Distribution and toxicityПодробнее

No, No He Didn’tПодробнее

Study shows mild COVID-19 induced lasting antibody protectionПодробнее

Predictors for Vaccine ProtectionПодробнее

Development of replication-deficient adenovirus malaria vaccines | RTCL.TVПодробнее

How long does protection from COVID-19 vaccines last?Подробнее

ADVAC Alumni webinar - 13 September 2022 - The power and limitations of immunobridging studiesПодробнее

Do more COVID-19 antibodies mean more protection?Подробнее

Model Informed Drug Development Approaches for Immunogenicity Assessments WorkshopПодробнее

BO-112: Enhancing immune-checkpoint inhibition in solid tumorsПодробнее

How much protection do we get from COVID-19 antibodies?Подробнее

VERIFY: Antibodies and immunityПодробнее

Answering COVID vaccine questions: Can a vaccinated person receive monoclonal antibodies? Is it ...Подробнее

Global HIV Vaccine Enterprise annual stakeholders meeting: Accelerating early phase vaccine researchПодробнее

What are Immune Checkpoints?Подробнее

Dr. Peter Gilbert: Immune Correlates Analysis of the mRNA-1273 Vaccine Efficacy TrialПодробнее

VE-Panel 2B: Future design approaches for HIV vaccine efficacy trialsПодробнее

Role of TrimericS IgG Antibodies in monitoring the immune response of recipients of COVID-19...Подробнее